According to a recent LinkedIn post from Clasp, Axios has featured the company’s $20 million Series B financing, which the post notes was led by Crosslink Capital and Digitalis Ventures. The post indicates that this brings Clasp’s total capital raised to $50 million, signaling continued investor interest in its healthcare-focused hiring platform.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights a strategy aimed at addressing challenges that arise after clinicians are hired, rather than focusing solely on initial recruitment incentives. Clasp suggests it is building tools to widen talent pools, engage healthcare professionals earlier, and support retention for more than three years after hire, a positioning that may appeal to health systems seeking to reduce turnover costs.
For investors, the described funding round could provide Clasp with additional resources to scale its technology, deepen product development, and expand its customer base in the healthcare sector. If the company can demonstrate measurable improvements in clinician retention and staffing stability, its platform could gain traction as a cost-saving solution and strengthen its competitive standing in healthcare workforce technology.
The Axios coverage referenced in the post may also enhance Clasp’s visibility among both potential clients and future investors. Increased media attention, combined with backing from established venture firms, could support future fundraising efforts and partnerships, although the ultimate financial impact will depend on the company’s execution and adoption rates in a highly competitive market.

